MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 7, 2006; DOI: 10.1124/mol.105.021436


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.021436v1
70/3/851    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, G. J.
Right arrow Articles by Bennett, M. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, G. J.
Right arrow Articles by Bennett, M. R


Received for publication December 2, 2005.
Revised May 30, 2006.
Accepted for publication June 6, 2006.

Purine Release from Spinal Cord Microglia Following Elevation of Calcium by Glutamate

Guo Jun Liu 1, Adrianna Kalous 1, Eryn L Werry 1, Max R Bennett 1*

1 University of Sydney

* Address correspondence to: E-mail: maxb{at}physiol.usyd.edu.au

Abstract

The propagation of Ca2+ waves in a network of microglial cells, following its initiation by glutamate, is mediated by purinergic transmission. Here we investigate the mechanisms by which glutamate releases ATP from cultured spinal cord microglia. The four-fold increase in ATP release from microglia in response to glutamate (0.5 mM) is blocked by alpha-amino-hydroxy-5-methyl-isoxazole-4-proprionate (AMPA)/kainate receptor antagonist 6-cyano-7-nitroguinoxaline-2,3-dione (CNQX) and specific AMPA receptor antagonist 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride (GYKI 52466) but not by N-methyl-D-aspartic acid (NMDA) or metabotropic glutamate receptor antagonists. Glutamate acting on AMPA receptors evokes an ATP release which is blocked by antagonizing the rise in intracellular Ca2+ due to its release from internal stores as well as by antagonizing protein kinase C with chelerythrine. Glutamate-stimulated ATP release is significantly antagonized by the cystic fibrosis transmembrane conductance regulator (CFTR) blockers flufenamic acid and glibenclamide. A role for the CFTR was further confirmed using microglia from CFTR knockout mice which released significantly less ATP than microglia from control wild type mice in response to glutamate. Use of 6-methoxy-1-(3-sulfopropyl)quinolinium (SPQ) fluorescence assay revealed functional CFTR in microglia. These observations suggest that glutamate acts on microglial AMPA receptors to stimulate release of Ca2+ from intracellular stores as well as a Ca2+-dependent isoform of protein kinase C which then acts to trigger release of ATP with the CFTR acting as a regulator of the ATP release process, perhaps through another channel or transporter.


Key words: Purinergic, Glutamate, Purinergic, Gi family, Gq/11 family, Protein Kinase C, Ion transporters (SERCA, Na/K ATPase, CFTR), Ca imaging, Fluorescence techniques, Immunocytochemistry


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
E. Odgaard, H. A. Praetorius, and J. Leipziger
AVP-stimulated nucleotide secretion in perfused mouse medullary thick ascending limb and cortical collecting duct
Am J Physiol Renal Physiol, August 1, 2009; 297(2): F341 - F349.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics